GeneOne Life Science, Inc.
Founded in 1976 and listed on the KOSPI in 1987, GeneOne Life Science is a biologics CDMO and drug developer that co-developed the MERS DNA vaccine GLS-5300 with Inovio.
Price
Change
Market cap
Products & technology
- cGMP Plasmid DNARaw material for gene therapies and DNA vaccines (clinical/nonclinical use)
Clinical trials
data.go.kr7 MFDS clinical trial authorisations · 2013–2021 (Phase 1 5 · Phase 2 1 · Phase 1/2a 1)
- Phase 2GLS-10272021-09-08
6 trial sites
- Phase 1GLS-61002021-05-20
1 trial site
- Phase 1/2aGLS-53102020-12-04
5 trial sites
- Phase 1GLS-61502018-02-02
2 trial sites
- Phase 1GLS-53002017-09-14
2 trial sites
- Phase 1GLS-61502014-09-26
2 trial sites
- Phase 1GLS-61502013-10-18
2 trial sites
R&D and key agreements
Source: DART corporate disclosureGLS-5300 · 중동호흡기증후군(MERS) · 임상1상(해외), 임상1/2a상(국내) 완료(2020년 4월 종료) · A DNA vaccine to prevent MERS coronavirus infection; Phase 1 results showed strong safety and immune response, with immune responses comparable to recovered MERS patients maintained 60 weeks after vaccination.
mRNA 생산 플랫폼 · 생산공정 스케일업 진행중 · Preparing mRNA vaccine and therapeutic CDMO services based on mRNA production technology licensed from HMRI.
Companies in the same categoryPharma & CDMO
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Founded and listed on KOSDAQ in 2015, Kolmar BioTech is a nonclinical CRO providing efficacy testing for anticancer and metabolic disease drug candidates.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition